Genetic Association of Phosphodiesterases With Human Cognitive Performance

por Gurney, Mark E.
Publicado 2019

The Use of Facebook Advertising to Recruit Healthy Elderly People for a Clinical Trial: Baseline Metrics

por Cowie, Julie M, Gurney, Mark E
Publicado 2018

Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis

por Zhou, Mengshi, Xu, Rong, Kaelber, David C., Gurney, Mark E.
Publicado 2020

Therapeutic benefits of phosphodiesterase 4B inhibition after traumatic brain injury

por Wilson, Nicole M., Gurney, Mark E., Dietrich, W. Dalton, Atkins, Coleen M.
Publicado 2017

Multiple Behavior Phenotypes of the Fragile-X Syndrome Mouse Model Respond to Chronic Inhibition of Phosphodiesterase-4D (PDE4D)

por Gurney, Mark E., Cogram, Patricia, Deacon, Robert M, Rex, Christopher, Tranfaglia, Michael
Publicado 2017

Comparison of the Pharmacological Profiles of Selective PDE4B and PDE4D Inhibitors in the Central Nervous System

por Zhang, Chong, Xu, Ying, Zhang, Han-Ting, Gurney, Mark E., O’Donnell, James M.
Publicado 2017

Gut–microbiota–microglia–brain interactions in Alzheimer’s disease: knowledge-based, multi-dimensional characterization

por Wang, QuanQiu, Davis, Pamela B., Qi, Xin, Chen, Shu G., Gurney, Mark E., Perry, George, Doraiswamy, P. Murali, Xu, Rong
Publicado 2021

Protection from Amyloid β Peptide–Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor

por Cui, Su-Ying, Yang, Ming-Xin, Zhang, Yong-He, Zheng, Victor, Zhang, Han-Ting, Gurney, Mark E., Xu, Ying, O’Donnell, James M.
Publicado 2019

A Novel PDE4D Inhibitor BPN14770 Reverses Scopolamine-Induced Cognitive Deficits via cAMP/SIRT1/Akt/Bcl-2 Pathway

por Wang, Yulu, Gao, Shichao, Zheng, Victor, Chen, Ling, Ma, Min, Shen, Shichen, Qu, Jun, Zhang, Hanting, Gurney, Mark E., O’Donnell, James M., Xu, Ying
Publicado 2020

Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice

por Zhang, Chong, Xu, Ying, Chowdhary, Anirudh, Fox, David, Gurney, Mark E., Zhang, Han-Ting, Auerbach, Benjamin D., Salvi, Richard J., Yang, Mingxin, Li, Gaowen, O’Donnell, James M.
Publicado 2018

Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography

por Davies, Douglas R., Mamat, Bjorn, Magnusson, Olafur T., Christensen, Jeff, Haraldsson, Magnus H., Mishra, Rama, Pease, Brian, Hansen, Erik, Singh, Jasbir, Zembower, David, Kim, Hidong, Kiselyov, Alex S., Burgin, Alex B., Gurney, Mark E., Stewart, Lance J.
Publicado 2009

Corrections to Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography

por Davies, Douglas R., Mamat, Bjorn, Magnusson, Olafur T., Christensen, Jeff, Haraldsson, Magnus H., Mishra, Rama, Pease, Brian, Hansen, Erik, Singh, Jasbir, Zembower, David, Kim, Hidong, Kiselyov, Alex S., Burgin, Alex B., Gurney, Mark E., Stewart, Lance J.
Publicado 2010